
TScan Therapeutics (TCRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy TScan Therapeutics (TCRX) Stock
Start investing in TScan Therapeutics (TCRX)
About TScan Therapeutics (TCRX)
Market cap | $81.49M |
Today's volume | 119.89K |
Revenue (TTM) | $4.42M |
Avg. daily volume | 562.77K |
EBITDA (TTM) | -$136.17M |
Open | $1.41 |
Price / earnings ratio | -1.32x |
Today's range | $1.41 - $1.51 |
Debt / equity | 46.16x |
52 week range | $1.02 - $7.89 |
5 year debt / equity | 43.17x |
Beta (LTM) | 1.02x |
Interest coverage | -36.91x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 8.55x |
Ex-dividend date | — |
Next earnings | Aug 11, 2025 |
Dividend payable date | — |
TScan Therapeutics Stock Rating
TScan Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy TCRX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in TCRX stock
Navigate to the Explore page. Then, type TCRX into the search bar. When you see TCRX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased TCRX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
TScan Therapeutics Stock Earnings
The value each TCRX share was expected to gain vs. the value that each TCRX share actually gained.
TScan Therapeutics (TCRX) reported Q1 2025 earnings per share (EPS) of -$0.26, beating estimates of -$0.28 by 7.14%. In the same quarter last year, TScan Therapeutics's earnings per share (EPS) was -$0.32. TScan Therapeutics is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of -$0.32.